Hypertropic Cardiomyopathy - Pipeline Review, H2 2012

Publisher Name :
Date: 31-Oct-2012
No. of pages: 32
Inquire Before Buying

Hypertropic Cardiomyopathy - Pipeline Review, H2 2012

Summary

Global Markets Direct's, 'Hypertropic Cardiomyopathy - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hypertropic Cardiomyopathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hypertropic Cardiomyopathy. Hypertropic Cardiomyopathy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Hypertropic Cardiomyopathy.
- A review of the Hypertropic Cardiomyopathy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Hypertropic Cardiomyopathy pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Hypertropic Cardiomyopathy.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Hypertropic Cardiomyopathy pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Hypertropic Cardiomyopathy - Pipeline Review, H2 2012

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Hypertropic Cardiomyopathy Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Hypertropic Cardiomyopathy 7
Hypertropic Cardiomyopathy Therapeutics under Development by Companies 9
Hypertropic Cardiomyopathy Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Hypertropic Cardiomyopathy Therapeutics - Products under Development by Companies 13
Hypertropic Cardiomyopathy Therapeutics - Products under Investigation by Universities/Institutes 14
Companies Involved in Hypertropic Cardiomyopathy Therapeutics Development 15
Novartis AG 15
Hypertropic Cardiomyopathy - Therapeutics Assessment 16
Assessment by Monotherapy Products 16
Assessment by Route of Administration 17
Assessment by Molecule Type 19
Drug Profiles 21
ARRY-162 - Drug Profile 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
perhexiline - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
diltiazem hydrochloride - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
atorvastatin calcium - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
losartan potassium - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
losartan potassium - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Hypertropic Cardiomyopathy Therapeutics - Drug Profile Updates 29
Hypertropic Cardiomyopathy Therapeutics - Dormant Products 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32

List of Tables
Number of Products Under Development for Hypertropic Cardiomyopathy, H2 2012 7
Products under Development for Hypertropic Cardiomyopathy - Comparative Analysis, H2 2012 8
Number of Products under Development by Companies, H2 2012 9
Number of Products under Investigation by Universities/Institutes, H2 2012 10
Comparative Analysis by Late Stage Development, H2 2012 11
Comparative Analysis by Mid Clinical Stage Development, H2 2012 12
Products under Development by Companies, H2 2012 13
Products under Investigation by Universities/Institutes, H2 2012 14
Novartis AG, H2 2012 15
Assessment by Monotherapy Products, H2 2012 16
Assessment by Stage and Route of Administration, H2 2012 18
Assessment by Stage and Molecule Type, H2 2012 20
Hypertropic Cardiomyopathy Therapeutics - Drug Profile Updates 29
Hypertropic Cardiomyopathy Therapeutics - Dormant Products 30

List of Figures
Number of Products under Development for Hypertropic Cardiomyopathy, H2 2012 7
Products under Development for Hypertropic Cardiomyopathy - Comparative Analysis, H2 2012 8
Products under Development by Companies, H2 2012 9
Products under Investigation by Universities/Institutes, H2 2012 10
Late Stage Products, H2 2012 11
Mid Clinical Stage Products, H2 2012 12
Assessment by Monotherapy Products, H2 2012 16
Assessment by Route of Administration, H2 2012 17
Assessment by Stage and Route of Administration, H2 2012 18
Assessment by Molecule Type, H2 2012 19
Assessment by Stage and Molecule Type, H2 2012 20

  • Siemens Adds To the Growth of Wind Power Generation Market
    Siemens has been presenting ground-breaking strategies and pioneering solutions for energy generation for an intelligent power supply globally. With an expansive portfolio and wide-ranging proficiency in wind power generation, Siemens is likely to aid in increasing the share of wind power in the US energy mix. With New Mexico’s vicinity to significant wind energy areas, [...]
  • Global Public Safety LTE Ecosystem Overview
    In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
  • RnR Market Research: Biochips Market Insights
    Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
  • Current State of Blood Banking Market, Products, Technologies and Services
    The global blood banking and blood products market is expected to reach US$41.9 billion by 2020 with USA continuing to be the largest market worldwide. Asia-Pacific follows a close second with a projected CAGR of 9.1% during this period owing to the refining healthcare infrastructure and increase in the per capita healthcare expenditure. The major [...]
  • Surgical Robots Market 2016 Updates on Companies, Products and More
    Surgical robots are medical devices that assist surgeons in performing many types of complex procedures with more accuracy, flexibility and control than is possible with conventional techniques. The aim of surgical robots market players is to provide improved diagnostic skills, a less invasive and more comfortable experience for the patient, and the ability to do [...]
  • U.S. Therapeutic Plasma Exchange Market by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Guillain Barre Syndrome, Multiple Sclerosis, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - Forecasts to 2021
    Published: 19-Jul-2016        Price: US 5650 Onwards        Pages: 91
    The U.S. therapeutic plasma exchange (TPE) market by indication is estimated to reach USD 260.0 million by 2021, growing at a CAGR of 11% to 12% during the forecast period (2016 to 2021). The rising incidences of blood disorders and chronic diseases; rapid increase in the aging population; and increasing adoption of therapeutic plasma exchange in rare neurological, hematology, and autoimmune disorders are key factors driving the therapeutic plasma exchange market in the U.S. In this report, t......
  • Global Sexual Dysfunction Partnering 2010 to 2016
    Published: 01-Jul-2016        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary Provides understanding and access t- the sexual dysfunction partnering deals and agreements entered int- by the worlds leading healthcare companies. The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access t- partnering deals and agreements entered int- by the world's leading healthcare companies. - Trends in partne......
  • Global Musculoskeletal Partnering 2010-2016: Deal trends, players and financials
    Published: 01-Jul-2016        Price: US 2995 Onwards        Pages: 1000
    "Delivery of this report will take 1-3 days after purchase." Summary Global Musculoskeletal Partnering 2010-2016: Deal trends, players and financials provides comprehensive understanding and unprecedented access t- the musculoskeletal partnering deals and agreements entered int- by the worlds leading healthcare companies Global Musculoskeletal Partnering 2010 t- 2016 provides the full collection of Musculoskeletal disease deals signed between ......
  • Global Sexual Health Partnering 2010-2016: Deal trends, players and financials
    Published: 01-Jul-2016        Price: US 2995 Onwards        Pages: 250
    "Delivery of this report will take 1-3 days after purchase." Summary The Global Sexual Health Partnering 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access t- the sexual health partnering deals and agreements entered int- by the worlds leading healthcare companies Global Sexual Health Partnering 2010 t- 2016 provides the full collection of Sexual Health disease deals signed betwe......
  • Global Musculoskeletal Symptoms Partnering 2010-2016
    Published: 01-Jul-2016        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary Provides understanding and access t- the musculoskeletal symptoms partnering deals and agreements entered int- by the worlds leading healthcare companies. The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access t- partnering deals and agreements entered int- by the world's leading healthcare companies. - Trends in ......
  • Global Hypercholesterolemia Partnering 2010 to 2016
    Published: 01-Jul-2016        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary The Hypercholesterolemia Partnering 2010-2015 report provides understanding and access t- the hypercholesterolemia partnering deals and agreements entered int- by the worlds leading healthcare companies. The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access t- partnering deals and agreements entered int- by the world's leading ......
  • Global Cystic Fibrosis Partnering 2010 to 2016
    Published: 01-Jul-2016        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary Provides understanding and access t- the cystic fibrosis partnering deals and agreements entered int- by the worlds leading healthcare companies. The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access t- partnering deals and agreements entered int- by the world's leading healthcare companies. - Trends in partnerin......
  • Global Infertility Partnering 2010 to 2016
    Published: 01-Jul-2016        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary Provides understanding and access t- the infertility partnering deals and agreements entered int- by the worlds leading healthcare companies. The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access t- partnering deals and agreements entered int- by the world's leading healthcare companies. - Trends in partnering de......
  • Global Transplantation Partnering 2010 to 2016
    Published: 01-Jul-2016        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary Provides understanding and access t- the transplantation partnering deals and agreements entered int- by the worlds leading healthcare companies. The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access t- partnering deals and agreements entered int- by the world's leading healthcare companies. - Trends in partnerin......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs